251 results
Page 9 of 13
8-K
EX-99.1
zcbl83
14 Feb 19
Results of Operations and Financial Condition
7:05am
8-K
EX-99.2
yf2tkgb zai
14 Feb 19
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
w6jt07s1b2rc1e0vu
1 Feb 19
Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application
4:33pm
8-K
EX-99.1
haewdo n15fh2f
7 Jan 19
Results of Operations and Financial Condition
7:13am
8-K
szeo t211kj4etl17z
29 Nov 18
Alkermes Announces Positive Topline Results FromENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia
7:17am
8-K
EX-99.1
fcieocxy
29 Nov 18
Alkermes Announces Positive Topline Results FromENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia
7:17am
8-K
nkskv7j0
2 Nov 18
Regulation FD Disclosure
12:00am
8-K
EX-99.1
hv66uvful l0
2 Nov 18
Regulation FD Disclosure
12:00am
8-K
EX-99.1
wzy95z1elxm
23 Oct 18
Results of Operations and Financial Condition
8:15am
8-K
EX-99.2
7u25d7ault910zjo4
23 Oct 18
Results of Operations and Financial Condition
8:15am
S-8
EX-5.1
rcd7f6o
26 Jul 18
Registration of securities for employees
4:13pm
8-K
EX-99.1
znz6n3ar
26 Jul 18
Results of Operations and Financial Condition
7:05am
8-K
EX-99.2
9hag ku47j8hjf
26 Jul 18
Results of Operations and Financial Condition
7:05am
8-K
3jig6hc9d csywah
2 Jul 18
Regulation FD Disclosure
7:14am
8-K
EX-99.1
e7qj5r
2 Jul 18
Regulation FD Disclosure
7:14am
8-K
EX-99.1
6embn395lh 47ml
26 Apr 18
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
8sacpqi5rmllva
26 Apr 18
Results of Operations and Financial Condition
12:00am